| REVIEW ARTICLE |
|
| Year : 2012 | Volume
: 3
| Issue : 4 | Page : 300-303 |
|
|
Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis
Jaykaran Charan1, Jagdish P Goyal2, Deepak Saxena3, Preeti Yadav1
1 Department of Pharmacology, Govt. Medical College, Rajkot, India
2 Department of Pharmacology, P. D. U. Govt. Medical College, Rajkot, India
3 Department of Epidemiology, Indian Institute of Public Health, Ahmedabad, Gujarat, India
Correspondence Address:
Jaykaran Charan
Department of Pharmacology, Govt. Medical College, Surat, Gujarat
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0976-500X.103685
|
|
|
Objectives : To explore the effect of vitamin D supplementation in prevention of respiratory tract infections on the basis of published clinical trials. Materials and Methods : Clinical trials were searched from various electronic databases. Five clinical trials were suitable for inclusion. Outcome was events of respiratory tract infections in vitamin D group and placebo group. Data was reported as odds ratio with 95% confidence interval. Both random and fixed model was used for analysis. Analysis was done with the help of Comprehensive meta-analysis software 2. Results : Events of respiratory tract infections were significantly lower in vitamin D group as compared to control group [Odds ratio = 0.582 (0.417 - 0.812) P = 0.001] according to random model. Results were similar in fixed model. On separate analysis of clinical trials dealing with groups of children and adults, beneficial effect of vitamin D was observed in both, according to fixed model [Odds ratio = 0.579 (0.416 - 0.805), P = 0.001 and Odd ratio = 0.653 (0.472 - 0.9040, P = 0.010 respectively]. On using random model beneficial effect persisted in children's group but became nonsignificant in adults group [Odds ratio = 0.579 (0.416 - 0.805), P = 0.001 and Odd ratio = 0.544 (0.278 - 1.063) P = 0.075 respectively]. Conclusion : Vitamin D supplementation decreases the events related to respiratory tract infections. There is need of more well conducted clinical trials to reach to a certain conclusion. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
